London, England, United Kingdom
Senior life-sciences executive with 15+ years of strategic business development, consulting and leadership experience. Passionate about driving global partnerships, developing evidence-based innovations and scaling equitable healthcare solutions. Lifelong learner and trusted steward of high-impact collaborations. #SDGs #ESG #SocialPrescribing. Let's connect! Past projects in the pharma & biotech space have included facilitating adaptive patient-centric precision-medicine clinical trials, planning regulatory IND/CTA/NDA/BLA submissions, developing commercial launch/market access/licensing/fundraising strategies, evaluating early/late stage investment/exit strategies and leveraging real-world data/evidence (RWD/RWE) and HEOR (health economics and outcomes research) in hybrid decentralized projects (e.g. via telehealth, IoT, edge computing sensors, medical devices etc.). Always looking to align with the sustainable development goals. Twitter/X: @garyquashie
Our mission: Extend, improve and save lives of people suffering from several of the world's biggest causes of death and disability such as hypertension, diabetes and other cardiometabolic diseases. George Medicines is an independent spin-out of The George Institute for Global Health, one of the world's leading medical research institutes, with a focus on addressing global health inequity. In my role, I lead end-to-end licensing and alliances by: - Structuring collaborations (in-/out-licensing, co-development, access agreements) - Empowering our alliances (JSC/JDC, insights, value realisation) - Guiding cross-functional diligence (scientific / clinical / regulatory / valuation) - Driving partnership activities (search & evaluation to term-sheet to signature) - Shaping evidence generation and access straegies (future trials, RWE/RWE, HEOR) We aim to deliver affordable evidence based therapies for patients, communities and health systems. See our website for more informaiton on our lead program Widaplik (GMRx2).
As a Clinical Research Organization (CRO) that's built for biotech, Premier Research are dedicated to helping innovators turn ideas into life-changing treatments for patients around the globe. Indication areas of focus include oncology, immunology, CNS, infectious diseases, cell & gene therapy, biologics (incl. vaccines & monoclonal/polyclonal antibodies), rare diseases, cardiovascular, gastrointestinal, respiratory, ophthalmology, metabolic disorders, dermatology, musculoskeletal, genitourinary disorders, women’s and male health, mouth and dental disorders, hematology, ear nose throat hormonal & nutritional disorders.
For 25+ years, Opis Research's long-serving team of experienced project managers, expert medics and critical thought leaders have facilitated clinical trials all across the globe. Our biotech, diagnostics and medical device clients benefit from various services such as: - Trial design & execution (3+3, non-inferiority, RCT, external control arm, SAD/MAD, adaptive, safety etc.) - Regulatory support (IND/CTA/NDA/BLA applications, EU-CTR/CBER/CDER/OCE/CDRH strategy, etc.) - Pre-clinical; scientific advice, IND-enabling, PK/PD, toxicology, GLP, IMPD writing, QA audits) - Rescue study help, vendor management, ISO compliance, feasibility/enrollment, trial extension, site selection - Clinical.net EDC, ePRO, biostats, database lock & clean data transfer, ICH/GCP and GDPR compliance - Pharmacovigilance (SDEA/SMP prep, AE reporting, SAE reconciliation, SUSAR submission etc.)
Parexel supports the development of medical products through clinical services, regulatory planning and market access consulting across various sub indications and molecule types. Areas include: - Early Development + Ph I-IV Trials, Bioequivalence Studies, Proof of Concept - Adaptive & Decentralized Trials, Site Selection, Patient Engagement/Recruitment, - Regulatory & Access Consulting, Integrated Technologies, Wearable Technologies - Supplies & Logistics, Feasibility Planning, Study Design, Product Development - Functional Service Provider (FSP) Model, Medical Writing, - Communications, Patient Advocacy, Clinical Adjudication Services - Quantitative Clinical Development, Genomic Medicine Services
Our world is changing faster then ever before. GlobalData strives to decode the future by providing powerful data analytics, consultancy services and marketing intelligence. As Director, responsible for directly managing and growing our Americas team of business development specialists, various indication specific services were covered under the team such as: -Clinical Trial Design, Feasibility Planning, Patient Enrollment & Recruitment Optimization -Biomarker Research, Fundraising and Partnership Collaboration -Precision / Personalized Medicine Implementation -Cell & Gene Therapy/Editing, Regenerative Medicine -In/Out-Licensing, Market Access, Commercialization Activity -Valuations, Deal Benchmarking and Reimbursement -Competitive Intelligence, Evaluation & Analysis -Data Management, Integration and Economic Modeling -Product Management, Development and Patient Segmentation -Investor Fundraising, Influencer and Stakeholder Relationship Building
Interim role: By specializing in valuation analysis, mergers & acquisitions and market share growth, my role was focused on cultivating strategic partnerships and providing expert advise to key industries such as renewables, wind, solar photovoltaic (PV), hydro, bio, nuclear, smart grid, smart cities, oil & gas, equipment & services and transmission & distribution sectors with huge potential for new technologies like: - Connected Devices & Internet of Things (IoT) - Artificial Intelligence (AI) & Cloud Technology - Blockchain & Digital Business - Robotics & Drones - Data Mining & Deep learning - Payment Tech & Cyber Security - Machine Learning & Automation - Neural Networks & Deep Learning - Sensors & Edge Computing